Boston Scientific (BSX) Gross Margin (2009 - 2026)

Boston Scientific has disclosed Gross Margin across 18 years of filings, most recently posting 69.46% for Q1 2026.

• Gross Margin for Q1 2026 came in at 69.46%, up 62.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 69.17% (up 51.0% YoY), and the FY2025 annual result was 69.01%, up 41.0% from the prior year.
• Gross Margin came in at 69.46% for Q1 2026 at Boston Scientific, roughly flat from 69.6% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 70.63% in Q2 2023 to a low of 67.65% in Q2 2025.
• The 5-year median for Gross Margin is 68.85% (2022), against an average of 69.01%.
• Across the five-year window, Gross Margin jumped 180 bps in 2023 and plunged 152 bps in 2025, its largest moves.
• Boston Scientific's Gross Margin stood at 68.85% in 2022, then increased by 1 bps to 69.23% in 2023, then slipped by 2 bps to 67.86% in 2024, then advanced by 3 bps to 69.6% in 2025, then decreased by 0 bps to 69.46% in 2026.
• The last three Gross Margin figures came in at 69.46% (Q1 2026), 69.6% (Q4 2025), and 69.93% (Q3 2025), per Business Quant data.